These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30148766)

  • 21. Primary biliary cirrhosis in India.
    Sarin SK; Monga R; Sandhu BS; Sharma BC; Sakhuja P; Malhotra V
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):105-9. PubMed ID: 16481294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
    Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
    Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase.
    Zachou K; Rigopoulou E; Liaskos C; Patsiaoura K; Makri E; Stathakis N; Dalekos GN
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):425-8. PubMed ID: 15028978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Risk Factors for Autoimmune Thyroid Disease might Affect the Susceptibility to and Modulate the Progression of Primary Biliary Cholangitis.
    Kuś A; Arłukowicz-Grabowska M; Szymański K; Wunsch E; Milkiewicz M; Płoski R; Shums Z; Norman GL; Milkiewicz P; Bednarczuk T; Krawczyk M
    J Gastrointestin Liver Dis; 2017 Sep; 26(3):245-252. PubMed ID: 28922436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
    Montano-Loza AJ; Hansen BE; Corpechot C; Roccarina D; Thorburn D; Trivedi P; Hirschfield G; McDowell P; Poupon R; Dumortier J; Bosch A; Giostria E; Conti F; Parés A; Reig A; Floreani A; Russo FP; Goet JC; Harms MH; van Buuren H; Van den Ende N; Nevens F; Verhelst X; Donato MF; Malinverno F; Ebadi M; Mason AL;
    Gastroenterology; 2019 Jan; 156(1):96-107.e1. PubMed ID: 30296431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
    Sherlock S
    Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis.
    Ikeda F; Okamoto R; Baba N; Fujioka S; Shoji B; Yabushita K; Ando M; Matsumura S; Kubota J; Yasunaka T; Miyake Y; Iwasaki Y; Kobashi H; Okada H; Yamamoto K
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1320-8. PubMed ID: 22414162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a Primary Biliary Cholangitis-Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBC.
    Younossi ZM; Stepanova M; Younossi I; Racila A
    Clin Transl Gastroenterol; 2024 Sep; 15(9):e1. PubMed ID: 38738764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Hao YL; Bian ZL; Ju LL; Liu Y; Qin G
    Dig Dis Sci; 2020 Feb; 65(2):470-479. PubMed ID: 31377883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
    Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
    Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
    Mayo MJ; Carey E; Smith HT; Mospan AR; McLaughlin M; Thompson A; Morris HL; Sandefur R; Kim WR; Bowlus C; ; Levy C
    Dig Dis Sci; 2023 Mar; 68(3):995-1005. PubMed ID: 35704252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    Shaheen AA; Kaplan GG; Almishri W; Vallerand I; Frolkis AD; Patten S; Swain MG
    PLoS One; 2018; 13(4):e0194839. PubMed ID: 29617396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic implications of extra-hepatic clinical manifestations, autoimmunity and microscopic nail capillaroscopy in patients with primary biliary cirrhosis].
    Marí-Alfonso B; Amengual-Guedan MJ; Vergara-Gómez M; Simeón-Aznar CP; Fonollosa-Plà V; Jove-Buxeda E; Oliva-Morera J; Tolosa-Vilella C
    Med Clin (Barc); 2016 Jan; 146(1):8-15. PubMed ID: 25978920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states.
    Parikh-Patel A; Gold EB; Worman H; Krivy KE; Gershwin ME
    Hepatology; 2001 Jan; 33(1):16-21. PubMed ID: 11124815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary biliary cirrhosis: safety and benefits of established and emerging therapies.
    Tabibian JH; Lindor KD
    Expert Opin Drug Saf; 2015; 14(9):1435-44. PubMed ID: 26212223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis.
    Kumagi T; Guindi M; Fischer SE; Arenovich T; Abdalian R; Coltescu C; Heathcote EJ; Hirschfield GM
    Am J Gastroenterol; 2010 Oct; 105(10):2186-94. PubMed ID: 20502446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.